Covalent modification of a volatile anesthetic regulatory site activates TASK-3 (KCNK9) tandem-pore potassium channels

Molecular Pharmacology

Volumn 81, Issue 3, 2012, Pages 393-400

  Conway, Kevin E ^a   Cotten, Joseph F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; G PROTEIN COUPLED RECEPTOR; ISOFLURANE; MUSCARINIC M1 RECEPTOR; N ETHYLMALEIMIDE; POLYPEPTIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL TASK3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL MEMBRANE; CONTROLLED STUDY; MOLECULAR INTERACTION; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; RAT; REGULATORY MECHANISM; THYROID CELL;

ANESTHETICS, INHALATION; ANIMALS; CELL LINE; CELLS, CULTURED; ETHYLMALEIMIDE; POTASSIUM CHANNELS, TANDEM PORE DOMAIN; RATS; RATS, INBRED F344; THYROID GLAND;

EID: 84857426302     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.111.076281     Document Type: Article

References (24)

1. Andres-Enguix I, Caley A, Yustos R, Schumacher MA, Spanu PD, Dickinson R, Maze M, and Franks NP (2007) Determinants of the anesthetic sensitivity of two-pore domain acid-sensitive potassium channels: molecular cloning of an anesthetic-activated potassium channel from Lymnaea stagnalis. J Biol Chem 282:20977-20990. (Pubitemid 47099953)
2. Bagriantsev SN, Peyronnet R, Clark KA, Honoré E, and Minor DL Jr (2011) Multiple modalities converge on a common gate to control K2P channel function. EMBO J 30:3594-3606.
3. Chemin J, Girard C, Duprat F, Lesage F, Romey G, and Lazdunski M (2003) Mechanisms underlying excitatory effects of group I metabotropic glutamate receptors via inhibition of 2P domain K+ channels. EMBO J 22:5403-5411. (Pubitemid 37279950)
4. Chen X, Talley EM, Patel N, Gomis A, McIntire WE, Dong B, Viana F, Garrison JC, and Bayliss DA (2006) Inhibition of a background potassium channel by Gq protein alpha-subunits. Proc Natl Acad Sci USA 103:3422-3427. (Pubitemid 43346484)
5. Cotten JF and Welsh MJ (1998) Covalent modification of the nucleotide binding domains of cystic fibrosis transmembrane conductance regulator. J Biol Chem 273:31873-31879. (Pubitemid 29177124)
6. Czirják G, Petheo GL, Spät A, and Enyedi P (2001) Inhibition of TASK-1 potassium channel by phospholipase C. Am J Physiol Cell Physiol 281:C700-C708.
7. Franks NP (2008) General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal. Nat Rev Neurosci 9:370-386.
8. Franks NP and Lieb WR (1984) Do general anaesthetics act by competitive binding to specific receptors? Nature 310:599-601. (Pubitemid 14053907)
9. Franks NP and Lieb WR (1993) Selective actions of volatile general anaesthetics at molecular and cellular levels. Br J Anaesth 71:65-76. (Pubitemid 23198782)
10. Hudetz AG, Wood JD, and Kampine JP (2003) Cholinergic reversal of isoflurane anesthesia in rats as measured by cross-approximate entropy of the electroencephalogram. Anesthesiology 99:1125-1131. (Pubitemid 37339458)
11. Kang D, Han J, and Kim D (2006) Mechanism of inhibition of TREK-2 (K2P10.1) by the Gq-coupled M3 muscarinic receptor. Am J Physiol Cell Physiol 291:C649-C656. (Pubitemid 44497591)
12. Kelz MB, Sun Y, Chen J, Cheng Meng Q, Moore JT, Veasey SC, Dixon S, Thornton M, Funato H, and Yanagisawa M (2008) An essential role for orexins in emergence from general anesthesia. Proc Natl Acad Sci USA 105:1309-1314. (Pubitemid 351397049)
13. +channel family. J Biol Chem 275:9340-9347.
14. Lazarenko RM, Willcox SC, Shu S, Berg AP, Jevtovic-Todorovic V, Talley EM, Chen X, and Bayliss DA (2010) Motoneuronal TASK channels contribute to immobilizing effects of inhalational general anesthetics. J Neurosci 30:7691-7704.
15. Lindner M, Leitner MG, Halaszovich CR, Hammond GR, and Oliver D (2011) Probing the regulation of TASK potassium channels by PI(4,5)P2 with switchable phosphoinositide phosphatases. J Physiol 589:3149-3162.
16. Lobo IA, Trudell JR, and Harris RA (2006) Accessibility to residues in transmembrane segment four of the glycine receptor. Neuropharmacology 50:174-181. (Pubitemid 43100003)
17. Luo T and Leung LS (2009) Basal forebrain histaminergic transmission modulates electroencephalographic activity and emergence from isoflurane anesthesia. Anesthesiology 111:725-733.
18. Pang DS, Robledo CJ, Carr DR, Gent TC, Vyssotski AL, Caley A, Zecharia AY, Wisden W, Brickley SG, and Franks NP (2009) An unexpected role for TASK-3 potassium channels in network oscillations with implications for sleep mechanisms and anesthetic action. Proc Natl Acad Sci USA 106:17546-17551.
19. Patel AJ, Honoré E, Lesage F, Fink M, Romey G, and Lazdunski M (1999) Inhalational anesthetics activate two-pore-domain background K+ channels. Nat Neurosci 2:422-426. (Pubitemid 30491251)
20. Sheppard DN, Carson MR, Ostedgaard LS, Denning GM, and Welsh MJ (1994) Expression of cystic fibrosis transmembrane conductance regulator in a model epithelium. Am J Physiol 266:L405-L413.
21. h by an inhalational anaesthetic and neurotransmitters in rat brainstem motoneurones. J Physiol 541:717-729.
22. Steriade M, McCormick DA, and Sejnowski TJ (1993) Thalamocortical oscillations in the sleeping and aroused brain. Science 262:679-685. (Pubitemid 23350685)
23. Talley EM and Bayliss DA (2002) Modulation of TASK-1 (Kcnk3) and TASK-3 (Kcnk9) potassium channels: volatile anesthetics and neurotransmitters share a molecular site of action. J Biol Chem 277:17733-17742. (Pubitemid 34967579)
24. Yost CS (2003) Update on tandem pore (2P) domain K+ channels. Curr Drug Targets 4:347-351.